Nikko Asset Management Americas, Inc. Gilead Sciences, Inc. Transaction History

Nikko Asset Management Americas, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 23, 2018	SELL	$72.84 - $88.8 $6.83 Million - $8.32 Million	-93,700 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $6.24 Million - $7.32 Million	87,700 Added 1461.67%	93,700 $6.77 Million
Q3 2017 Oct 10, 2017	BUY	$72.11 - $85.47 $432,660 - $512,820	6,000	6,000 $486,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.